Task: Answer the multiple-choice question.
Question: Which drug exhibits a -6.085\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: CCc1ccccc1NC(=O)CCc1c(C)nc(SC)nc1C
b: CN(C)CCCN(C(=O)c1ccc(S(=O)(=O)N(C)C)cc1)c1nc2ccc(F)cc2s1.Cl
c: CC1CCN(S(=O)(=O)c2ccc(NC(=O)CN3CCOCC3)cc2)CC1
d: Cn1cnc([N+](=O)[O-])c1S(=O)(=O)c1cccc(Cl)c1
e: COc1ccc(CCC(=O)Nc2cc([N+](=O)[O-])ccc2OC)cc1
Answer: c. CC1CCN(S(=O)(=O)c2ccc(NC(=O)CN3CCOCC3)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(S(=O)(=O)c2ccc(NC(=O)CN3CCOCC3)cc2)CC1
CC1CCN(S(=O)(=O)c2ccc(NC(=O)CN3CCOCC3)cc2)CC1
N-[4-(4-methylpiperidin-1-yl)sulfonylphenyl]-2-morpholin-4-ylacetamide